SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (176)5/10/1999 1:17:00 PM
From: LLCF  Read Replies (1) of 555
 
<In the UK rights offerings are common, and maybe they might spread
to the US.>

Yes rights offerings are a common way to raise capital all over Europe, HOWEVER thats because it's considered acceptable for these corporate giants (Volkswagen, Siemans,etc) to call on shareholders for more capital, almost as a courtesy so as not to dilute those holders with a secondary. While I agree that this is "better", I still find it humorous (funny ha-ha, or funny peculiar?).

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News